Mallika Lala

Associate Principal Scientist in the Quantitative Pharmacology and Pharmacometrics group · Merck · company speakers →

Is this you? Claim this profile →

No public contact links on file.

Speaking history

AACR Drug Discovery and Development (AACR D3)

21 July 2026 Boston, United States “Pembrolizumab 400 mg Q6W dosing: First clinical outcomes data from Keynote-555 cohort B in metastatic melanoma patients”

Sourcing speakers for your event?

Browse the speaker directory →